Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123510993 | 12351099 | 3 | F | 20160407 | 20160715 | 20160510 | 20160729 | EXP | IT-PFIZER INC-2016212696 | PFIZER | 75.00 | YR | M | Y | 123.00000 | KG | 20160729 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123510993 | 12351099 | 1 | PS | CARDURA | DOXAZOSIN MESYLATE | 1 | Oral | 4 MG, DAILY | 19668 | 4 | MG | MODIFIED-RELEASE TABLET | |||||||
| 123510993 | 12351099 | 2 | I | XIGDUO XR | DAPAGLIFLOZIN PROPANEDIOLMETFORMIN HYDROCHLORIDE | 1 | Oral | 10 MG, DAILY | Y | 0 | 10 | MG | |||||||
| 123510993 | 12351099 | 3 | I | KARVEZIDE | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | ||||||||
| 123510993 | 12351099 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 123510993 | 12351099 | 5 | C | APIDRA | INSULIN GLULISINE | 1 | 24 IU, UNK | 0 | 24 | IU | |||||||||
| 123510993 | 12351099 | 6 | C | HUMALOG | INSULIN LISPRO | 1 | 23 IU, UNK | 0 | 23 | IU | |||||||||
| 123510993 | 12351099 | 7 | C | PROVISACOR | ROSUVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 123510993 | 12351099 | 8 | C | CARDIOASPIRIN | ASPIRIN | 1 | Oral | 100 MG, UNK | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123510993 | 12351099 | 1 | Hypertension |
| 123510993 | 12351099 | 2 | Diabetes mellitus |
| 123510993 | 12351099 | 3 | Hypertension |
| 123510993 | 12351099 | 4 | Hypertension |
| 123510993 | 12351099 | 5 | Diabetes mellitus |
| 123510993 | 12351099 | 6 | Diabetes mellitus |
| 123510993 | 12351099 | 7 | Hypercholesterolaemia |
| 123510993 | 12351099 | 8 | Platelet aggregation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123510993 | 12351099 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123510993 | 12351099 | Asthenia | |
| 123510993 | 12351099 | Blood creatinine increased | |
| 123510993 | 12351099 | Drug interaction | |
| 123510993 | 12351099 | Glomerular filtration rate decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123510993 | 12351099 | 1 | 20080113 | 0 | ||
| 123510993 | 12351099 | 2 | 20160324 | 20160407 | 0 | |
| 123510993 | 12351099 | 3 | 20080919 | 0 | ||
| 123510993 | 12351099 | 4 | 20080221 | 0 | ||
| 123510993 | 12351099 | 5 | 20150325 | 0 | ||
| 123510993 | 12351099 | 6 | 20120501 | 20160407 | 0 | |
| 123510993 | 12351099 | 7 | 20080221 | 0 | ||
| 123510993 | 12351099 | 8 | 20080221 | 0 |